Related Experiment Videos
A case of recurrent metastatic thymoma showing a marked response to paclitaxel monotherapy
Shigeki Umemura1, Yoshihiko Segawa, Keiichi Fujiwara
1Department of Internal Medicine, National Shikoku Cancer Center Hospital, Matsuyama, Japan. sumemura@shikoku-cc.go.jp
Japanese Journal of Clinical Oncology
|September 27, 2002
Abstract:
We describe a case of recurrent metastatic thymoma showing an excellent response to salvage paclitaxel monotherapy. The patient had undergone a series of platinum-based chemotherapy treatments during the previous 20-month period and the patient's disease was considered resistant to such therapy at the start of treatment with paclitaxel. This is the first report to suggest that paclitaxel has anti-thymoma activity.